Global Blood Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GBT and other ETFs, options, and stocks.

About GBT

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. 

CEO
Ted W. Love
CEOTed W. Love
Employees
457
Employees457
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2011
Founded2011
Employees
457
Employees457

GBT Key Statistics

Market cap
4.60B
Market cap4.60B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
2.21M
Average volume2.21M
High today
$68.44
High today$68.44
Low today
$68.01
Low today$68.01
Open price
$68.05
Open price$68.05
Volume
2.68M
Volume2.68M
52 Week high
$73.02
52 Week high$73.02
52 Week low
$21.65
52 Week low$21.65

Analyst ratings

88%

of 16 ratings
Buy
12.5%
Hold
87.5%
Sell
0%

GBT Earnings

-$1.36
-$0.91
-$0.45
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 7, Pre-Market
ActualExpected Nov 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.